Clinical trial of Ayurvedic remedy for Covid shows groundbreaking resul

A groundbreaking interim report on a clinical trial being conducted in three hospitals has shown that Covid19 patients on natural treatment are resolving most symptoms earlier than those on conventional medicinesThe interim report on combination treatment of an Ayurvedic remedy called Immunofree by Corival Life Sciences and Nutraceutical called Reginmune by Biogetica have shown exceptional results as against the present government SOP of conventional medicines for coronavirus treatmentFurthermore numerous tests such as C reactive protein Procalcitonin D Dimer and RTPCR for novel coronavirus are also showing 20 to 60 per cent better improvement for the natural treatment when compared to conventional treatmentNumerous subjective endpoints such as body pain and fatigue are also leaning towards the natural treatment Both Clinicians Global Assessment of Symptoms and Subjects Global Assessment of Symptoms clearly showed improvements on both arms showing more significant data in the test groupAbout 8666 per cent of patients on the natural protocol have tested corona negative on day 5 vs 60 per cent of patients on the conventional treatments Moreover on the 10th day test all patients were negative which could help in keeping the hospitals less occupiedImmunofree and Reginmune are being studied in a oneofakind pharmaceutical controlled multicentre clinical trial in 3 hospitals in India This CTRIapproved trial is being conducted on moderate COVID19 positive patients at Government Medical Hospital Srikakulam Andhra Pradesh Parul Sevashram Hospital Vadodara Gujarat and Lokmanya Hospital Pune MaharashtraWhat sets this trial apart is the fact that it is the only time where half the patients in the trial have been given only natural treatment which is being compared against the conventional treatment in use in India for COVID19 patientsThis comparative study was achieved as a pilot study in Mumbai showed similar startling results This control on the randomised trial allows for a direct comparison between these protocols from the world of natural medicine and conventional medicineThe conventional treatment in use depends on the severity of the patient and includes HCQ Azithromycin Favipiravir and Cetirizine This trial also has a broader inclusion criteria than others conducted on natural medicine as it includes patients upto 70 years old with low oxygen saturation and comorbiditiesIt is significant to note that none of the patients on the natural treatment progressed past moderate needed ventilators or had any adverse events These precedent setting results have led to accelerated enrolment into this trial and statistically significant results should be ready by month endNumerous countries and states that have adopted or mandated natural treatment for novel coronavirus have shown mortality rates less than 110 of their neighbours China supposedly stopped the outbreak after mandating TCM treatmentGoa and Kerala both have 110th the mortality rate of neighbouring states Madagascar Central African Republic Ghana and other countries which adopted COVID Organics have seen tremendous results compared to other African countries that did not adopt the natural treatment WHO has now endorsed a clinical trial protocol for COVID natural medicines and this is one of the first studies proving natural medicine for COVIDIt is therefore hoped that India too mandates the use of these herbs for novel coronavirus treatment All these regions tend to be using a subset combination of Glycyrrhiza Glabra Artemisia Hypericum Mysorense Tinnispora Cardiflora Inula Racemosa Andrographis Paniculata and others contained in Immunofree which has 15 ingredientsMost remedies in use for Covid19 are repurposed antimalaria and antiviral drugs not made specifically for this new virus that presents itself in ways no virus ever has We are fortunate to have gotten approval for a very specific remedy that is now showing these startling results beyond our own expectations It is a matter of great pride for India that our ancient sciences are coming to the forefront with this new empirical evidence and showing the importance of Ayurveda in the pandemic Biogetica founder Apurve Mehra saidThe results of this study thus far are startling and I hope to see people across the globe helped by this multifaceted natural remedy which seems to apply to all who are preCovid Covid positive and postCovid We are now approaching AYUSH and ICMR to get listed as the first herbal treatment of Covid in India and look forward to government support in seeing this helping Indians and India Wockhardt Foundation founder Huzaifa Khorakiwala saidKeep scrolling to read more newsCatch up on all the latest Crime National International and Hatke news here Also download the new midday Android and iOS apps to get latest updates MidDay is now on Telegram Click here to join our channel middayinfomedialtd and stay updated with the latest newsThis story has been sourced from a third party syndicated feed agencies Midday accepts no responsibility or liability for its dependability trustworthiness reliability and data of the text Midday managementmiddaycom reserves the sole right to alter delete or remove without notice the content in its absolute discretion for any reason whatsoever